Bretshire Medical Clinic

CLIA Laboratory Citation Details

2
Total Citations
59
Total Deficiencyies
31
Unique D-Tags
CMS Certification Number 45D0490166
Address 7030 Bretshire, Houston, TX, 77016
City Houston
State TX
Zip Code77016
Phone(281) 463-1400

Citation History (2 surveys)

Survey - January 16, 2019

Survey Type: Standard

Survey Event ID: PUL713

Deficiency Tags: D5311 D5415

Summary:

Summary Statement of Deficiencies D5311 SPECIMEN SUBMISSION, HANDLING, AND REFERRAL CFR(s): 493.1242(a) The laboratory must establish and follow written policies and procedures for each of the following, if applicable: (1) Patient preparation. (2) Specimen collection. (3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (4) Specimen storage and preservation. (5) Conditions for specimen transportation. (6) Specimen processing. (7) Specimen acceptability and rejection. (8) Specimen referral. This STANDARD is not met as evidenced by: An unannounced onsite B-visit was conducted on 01/16/19. The laboratory had moved to their permanent location on 04/2018. Based on surveyor observations, review of laboratory records, and confirmed in interview, the laboratory failed to establish and written policies and procedures for patient collection and processing for the complete blood count (CBC) testing on the Sysmex KX21N hematology analyzer. Findings were: 1. Surveyor observations on 1/16/19 at 1116 hours in the laboratory revealed testing person (TP) #2 performed a CBC on patient JL13320. 2. Further review of the EDTA microtainer tube revealed no unique identifier. 3. An interview with TP#2 on 1/16/19 at 1120 hours revealed that since he "just collected the specimen, he knew who the patient was." He acknowledged that the microtube had no unique identifier on the tube. 4. Review of the laboratory records available revealed no written policy for the CBC patient collection and processing that included criteria for the following: (1) Patient preparation. (2) Specimen collection. (3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (4) Specimen storage and preservation. (5) Conditions for specimen transportation. (6) Specimen processing. (7) Specimen acceptability and rejection. (8) Specimen referral. 5. An interview with the primary testing person on 1/16/19 at 1230 hours confirmed the above findings. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: An unannounced onsite B-visit was conducted on 01/16/19. The laboratory had moved to their permanent location on 04/2018. A. Based on review of manufacturer's instructions, surveyor observations, and confirmed in interview, the laboratory failed to ensure that in-use Eight Check 3WP-Xtra QC (quality control) material were labeled with the revised expiration dates according to the manufacturer. Findings included: 1. Review of the manufacturer's instructions for the Eight Check 3WP-Xtra manufacturer's instructions (AQ578643B) revealed "Opened and recapped vials and vials whose caps have been pierced will retain stability for 14 days if stored at 2-8C." 2. A tour of the laboratory on 1/16/19 at 1108 hours in the laboratory revealed the laboratory stored Eight Check 3WP-Xtra quality control for the Sysmex KS-21N hematology analyzer in the refrigerator with no documentation of the revised expiration dates. Lot 83110710 exp 2/13/19 Lot 83110711 exp 2/13/19 Lot 83110712 exp 2/13/19 3. Review of the laboratory billing report from January 2018 to December 2018 revealed the laboratory performed 7356 CBC testing using the Sysmex KX21N hematology analyzer. Refer to patient alias list. 4. An interview with the primary testing person on 1/16/19 at 1130 hours confirmed the above findings. B. Based on review of manufacturer's instructions, surveyor observations, and confirmed in interview, the laboratory failed to ensure that in use reagents for the Sysmex KX-21N hematology analyzer were labeled with new expiration dates according to the manufacturer. Findings were: 1. Review of the "Maintenance and Supplies Replacement" section of the Sysmex KX-21N operator's manual (Revised October 1998) revealed that the expiration after opening for the Cell Pack reagent is 60 days. 2. Surveyor observations on 1/16/19 at 1110 hours in the laboratory revealed an in use Cell Pack (lot Y8297, exp 5/7/20) with no documentation of the opened or expiration date. 3. Review of the laboratory billing report from January 2018 to December 2018 revealed the laboratory performed 7356 CBC testing using the Sysmex KX21N hematology analyzer. Refer to patient alias list. 4. An interview with the primary testing person on 1/16/19 at 1130 hours in the laboratory confirmed the above findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 27, 2018

Survey Type: Standard

Survey Event ID: PUL712

Deficiency Tags: D0000 D1001 D2000 D5016 D5024 D5291 D5405 D5411 D5413 D1001 D2000 D3031 D5002 D3031 D5002 D5016 D5024 D5291 D5405 D5411 D5413 D5423 D5441 D5449 D5469 D5481 D5791 D5793 D6015 D6053 D6054 D6072 D6076 D6078 D6168 D6072 D6171 D5423 D5441 D5449 D5469 D5481 D5791 D5793 D6015 D6033 D6036 D6046 D6033 D6036 D6046 D6053 D6054 D6171 D6076 D6078 D6168

Summary:

Summary Statement of Deficiencies D0000 An unannounced onsite B-visit was conducted on 2/27/18. The laboratory was found out of compliance. The conditions not met were: D2000 - 42 C.F.R. 493.801 Enrollment and Testing of Samples D5002 - 42 C.F.R. 493.1201 Condition: Bacteriology; D5024 - 42 C.F.R. 493.1215 Condition: Hematology; D6033 - 42 C.F. R. 493.1409 Condition: Laboratories performing moderate complexity testing; technical consultant The facility representative was given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. _______________________________________________________________________________________ The laboratory was found out of compliance with the CLIA regulations. The conditions not met were: D2000 - 42 C.F.R. 493.801 Enrollment And Testing Of Samples D5002 - 42 C.F.R. 493.1201 Condition: Bacteriology ; D5016 - 42 C.F.R. 493.1210 Condition: Routine chemistry; D5024 - 42 C.F.R. 493.1215 Condition: Hematology; D6033 - 42 C.F.R. 493.1409 Condition: Laboratories performing moderate complexity testing; technical consultant; D6076 - 42 C.F.R. 493.1487 Condition: Laboratories performing high complexity testing; laboratory director; D6168 - 42 C.F.R. 493.1487 Condition: Laboratories performing high complexity testing; testing personnel The laboratory voluntarily suspended glucose testing on the Contour glucometer as documented in a letter from the laboratory director on August 15, 2017. The facility representative was given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access